The Johns Hopkins University Applied Physics Laboratory (APL), with help from The Boeing Company [NYSE: BA] and Iridium Communications Inc. [Nasdaq: IRDM], has successfully implemented a new space-based system to monitor Earth’s space environment. Known as the Active Magnetosphere and Planetary Electrodynamics Response Experiment (AMPERE), the system provides real-time magnetic field measurements using commercial satellites as part of a new observation network to forecast weather in space. This is the first step in developing a system that enables 24-hour tracking of Earth's response to supersonic blasts of plasma ejected from the sun at collection rates fast enough to one day enable forecasters to predict space weather effects.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/iridium/45153/
Hunter, Autumn, and Summer live in separate homes, with different guardians and last names. What they share is a host of troubled feelings toward the mother they barely know. Told in three voices chronicling the family’s story, FALLOUT is the stunning conclusion to the trilogy begun by CRANK and GLASS. Learn more about this author here: http://www.ellenhopkins.com/
Learn more about this book here: http://tinyurl.com/y2wuxuw YA
In Ellen Hopkins’s Perfect, the riveting companion to Impulse, four teens pursue their goals of perfection which are as different as the paths they take to get there. Everyone wants to be perfect. But what does that really mean? Only you can decide for you, what is perfect. Learn more about this book here, http://bit.ly/ruGJyX and here, TEEN.SimonandSchuster.com and its author here, http://www.ellenhopkins.com/ YA
The following statement is being issued by Jonathan Schochor, Chairman, Plaintiffs’ Steering Committee, regarding Jane Doe No. 1, et. al. v. Johns Hopkins Hospital, et al., No. 24-C-13-001041.
If you were a patient of, or treated by Johns Hopkins Hospital gynecologist, Dr. Nikita Levy, you are a member of a mandatory settlement class action.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/65136-dr-nikita-levy-class-action-lawsuit-johns-hopkins-hospital-gynecology
Watch the brand new trailer for HITCHCOCK - a love story about one of the most influential artists of the last century, Alfred Hitchcock, and his wife and partner Alma Reville. Set during the making of Hitchcock's seminal movie PSYCHO, Sir Anthony Hopkins and Dame Helen Mirren are joined by an all-star cast including Scarlett Johansson as Janet Leigh, Toni Collette as Hitchcock's assistant, and Jessica Biel as Vera Miles . IN CINEMAS JANUARY 10.
Academy Award winning film producer Jonathan Sanger has once again given us a provocative tale that reaches audiences at the core of their heart, only this time his medium is print instead of film. His book “Making the Elephant Man: A Producer’s Memoir” gives us an insider’s look at the creation of one of the first ever indie films and a box-office smash, as well as a peek into the early careers of movie greats David Lynch, Mel Brooks and Anthony Hopkins. Find out more at http://www.jonathansangerproductions.com/ non-fiction, memoir
The following statement is being issued by Jonathan Schochor, Chairman, Plaintiffs’ Steering Committee, regarding Jane Doe No. 1, et. al. v. Johns Hopkins Hospital, et al., No. 24-C-13-001041.
If you were a patient of, or were treated by Johns Hopkins Hospital gynecologist, Dr. Nikita Levy, you may be eligible for compensation from a class action Settlement
A $190 million dollar proposed Settlement has been reached that offers payments to eligible members of The Levy Settlement Class.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7281851-dr-nikita-levy-patients-class-action-settlement/
Lustgarten Foundation funded researchers at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins have designed a multi-analyte blood test that can detect the presence of pancreatic cancer as part of a panel of eight common cancers (pancreas, ovary, liver, stomach, esophagus, colorectum, lung and breast) as reported in the online edition of Science today. The test utilizes combined assays for genetic alterations and protein biomarkers and has the capacity not only to identify the presence of relatively early cancer, but also to localize the organ of origin of these cancers.
“The potential this has for pancreatic cancer is unprecedented,” says Anne Marie Lennon, M.D., Ph.D., Associate Professor of Medicine, Director, Pancreatic Cyst Center of the Ludwig Center at the Johns Hopkins Kimmel Cancer Center. “We know that in 80-85 percent of pancreatic cancer cases, it’s detected too late, leaving the patient with few options. Developing a blood screening test for pancreatic cancer has been an urgent goal, because catching the disease early will be the way we get to long-term survival.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8213751-lustgarten-foundation-pancreatic-cancer-blood-test/
